Stock Screener App

Frei -

Installieren

1.77

3.21% 0.055

Transcode Therapeutics Inc (RNAZ)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Finanzdaten der Transcode Therapeutics Inc-Aktie (RNAZ)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Operating Expenses	61.76% 6.7895	17.76	16.03	4.5612	4.2211
Operating Income/Loss	61.76% -6.7895	-17.76	-16.03	-4.5612	-4.2211
Nonoperating Income/Loss	80.29% 0.0397	0.2013	2.8095	-0.2949	-0.0554
Income/Loss From Continuing Operations Before Tax	61.55% -6.7498	-17.55	-	-4.8561	-4.2765
Income Tax Expense/Benefit, Deferred	99.87% 0.0003	0.2313	-	-	-
Net Income/Loss	62.05% -6.7501	-17.79	-13.44	-4.8561	-4.2765
Basic Average Shares	4.39% 0.9572	0.917	-	0.8337	0.8337
Diluted Average Shares	4.39% 0.9572	0.917	-	0.8337	0.8337
Basic Earnings Per Share	66.31% -7.17	-21.28	-	-5.82	-5.13
Diluted Earnings Per Share	66.31% -7.17	-21.28	-	-5.82	-5.13

CRMD

$7.85

3.09%

DBVT

$9.75

0.72%

CADL

$8.03

4.18%

GYRE

$5.85

0.17%

WVE

$3.18

5.07%

ATTO

$13.83

4.62%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters